Literature DB >> 35525542

Co-expression of recombinant RIPK3:MLKL complexes using the baculovirus-insect cell system.

Cheree Fitzgibbon1, Yanxiang Meng1, James M Murphy2.   

Abstract

Pseudokinase domains are found throughout the kingdoms of life and serve myriad roles in cell signaling. These domains, which resemble protein kinases but are catalytically-deficient, have been described principally as protein interaction domains. Broadly, pseudokinases have been reported to function as: allosteric regulators of conventional enzymes; scaffolds to nucleate assembly and/or localization of signaling complexes; molecular switches; or competitors of signaling complex assembly. From detailed structural and biochemical studies of individual pseudokinases, a picture of how they mediate protein interactions is beginning to emerge. Many such studies have relied on recombinant protein production in insect cells, where endogenous chaperones and modifying enzymes favor bona fide folding of pseudokinases. Here, we describe methods for co-expression of pseudokinases and their interactors in insect cells, as exemplified by the MLKL pseudokinase, which is the terminal effector in the necroptosis cell death pathway, and its upstream regulator kinase RIPK3. These methods are broadly applicable to co-expression of other pseudokinases with their interaction partners from bacmids using the baculovirus-insect cell expression system.
Copyright © 2022 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cell death; Necroptosis; Phosphorylation; Sf21 cells; Zombie proteins

Mesh:

Substances:

Year:  2022        PMID: 35525542     DOI: 10.1016/bs.mie.2022.03.029

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


  1 in total

1.  Human RIPK3 C-lobe phosphorylation is essential for necroptotic signaling.

Authors:  Yanxiang Meng; Christopher R Horne; Andre L Samson; Laura F Dagley; Samuel N Young; Jarrod J Sandow; Peter E Czabotar; James M Murphy
Journal:  Cell Death Dis       Date:  2022-06-23       Impact factor: 9.685

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.